Assay for chlamydia trachomatis by amplification and detection of chlamydia trachomatis pmpa gene
AssigneeBecton, Dickinson and Company
InventorsCourtney E. Maus, Jason P. Stevens, Danielle Koffenberger
Life of this patent
Estimating the term…
Loading patent…
AssigneeBecton, Dickinson and Company
InventorsCourtney E. Maus, Jason P. Stevens, Danielle Koffenberger
Estimating the term…
A region of the Chlamydia trachomatis pmpA gene has been identified which is useful for performing amplification assays to determine specifically whether C. trachomatis is present in the sample being tested. Oligonucleotides useful for detecting this gene by performing the polymerase chain reaction (PCR) are disclosed. The disclosed oligonucleotides can be used in an assay which is specific for multiple strains or serovars of C. trachomatis, including the variant E serovar, and which does not show cross reactivity with the genomes of other microorganisms or with human DNA. In addition, the disclosed oligonucleotides can be used to in a multiplex system. This invention also contemplates a kit including oligonucleotides, and optionally other reagents, for the detection of C. trachomatis using PCR.
A method for detecting Chlamydia trachomatis in a biological sample comprising:
An oligonucleotide set for the detection of the pmpA gene of Chlamydia trachomatis in a biological sample comprising at least one oligonucleotide probe that is detectably labeled and has a nucleotide sequence length of about 10 to about 50, and at least two oligonucleotide primers, each of which has a nucleotide sequence length of about 10 to about 150,
A kit for the detection of the pmpA gene of Chlamydia trachomatis in a biological sample comprising:
A method of detecting Chlamydia trachomatis in a biological comprising:
Dependencies are inferred from the claim text.